Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival
Protein & Cell · 2025
DOI: 10.1093/procel/pwaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Meng Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics & Gynecology Hospital of Fudan University, State Key Laboratory of Genetic and Development of Complex Phenotypes, Institutes of Biomedical…. Hauptthemen laut MEDLINE: Glutamine, Myeloid Cell Leukemia Sequence 1 Protein, Proto-Oncogene Proteins c-myc, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Glutamine provides carbon and nitrogen to support the proliferation of cancer cells. However, the precise reason why cancer cells are particularly dependent on glutamine remains unclear. In this study, we report that glutamine modulates the tumor suppressor F-box and WD repeat domain-containing 7 (FBW7) to promote cancer cell proliferation and survival. Specifically, lysine 604 (K604) in the sixth of the 7 substrate-recruiting WD repeats of FBW7 undergoes glutaminylation (Gln-K604) by glutaminyl tRNA synthetase. Gln-K604 inhibits SCFFBW7-mediated degradation of c-Myc and Mcl-1, enhances glutamine utilization, and stimulates nucleotide and DNA biosynthesis through the activation of c-Myc. Additionally, Gln-K604 promotes resistance to apoptosis by activating Mcl-1. In contrast, SIRT1 deglutaminylates Gln-K604, thereby reversing its effects. Cancer cells lacking Gln-K604 exhibit overexpression of c-Myc and Mcl-1 and display resistance to chemotherapy-induced apoptosis. Silencing both c-MYC and MCL-1 in these cells sensitizes them to chemotherapy. These findings indicate that the glutamine-mediated signal via Gln-K604 is a key driver of cancer progression and suggest potential strategies for targeted cancer therapies based on varying Gln-K604 status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics & Gynecology Hospital of Fudan University, State Key Laboratory of Genetic and Development of Complex Phenotypes, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Female Reproductive Endocrine Re…
- Huashan Hospital, Fudan University, Shanghai 200040, China.
- NHC Key Laboratory of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200032, China.
- Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.
ORCID-Profile: Chen-Ji Wang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Sanming Project of Medicine in Shenzhen
Zitieren
APA
Wang, M., Guo, F. S., Hou, D. S., Zhang, H. L., Chen, X. T., Shen, Y. X., Guo, Z. F., Zheng, Z. F., Hu, Y. P., Du, P. Z., Wang, C. J., Lin, Y., Yuan, Y. Y., Zhao, S. M., & Xu, W. (2025). Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival. Protein & Cell. https://doi.org/10.1093/procel/pwaf029
Vancouver
Wang M, Guo FS, Hou DS, Zhang HL, Chen XT, Shen YX, et al. Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival. Protein & Cell. 2025. doi:10.1093/procel/pwaf029
BibTeX
@article{Wang2025,
author = {Wang, Meng and Guo, Fu-Shen and Hou, Dai-Sen and Zhang, Hui-Lu and Chen, Xiang-Tian and Shen, Yan-Xin and Guo, Zi-Fan and Zheng, Zhi-Fang and Hu, Yu-Peng and Du, Pei-Zhun and Wang, Chen-Ji and Lin, Yan and Yuan, Yi-Yuan and Zhao, Shi-Min and Xu, Wei},
title = {Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival},
journal = {Protein & Cell},
year = {2025},
doi = {10.1093/procel/pwaf029}
}
EUVIMED